vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and CRA INTERNATIONAL, INC. (CRAI). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($270.7M vs $197.0M, roughly 1.4× CRA INTERNATIONAL, INC.). BALCHEM CORP runs the higher net margin — 14.9% vs 6.7%, a 8.2% gap on every dollar of revenue. On growth, CRA INTERNATIONAL, INC. posted the faster year-over-year revenue change (11.6% vs 8.1%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (7.5% CAGR vs 7.1%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
CRA INTERNATIONAL, INC.CRAIEarnings & Financial Report
CRA International, Inc. is a global consulting firm headquartered in Boston. The firm provides expert testimony and litigation support, strategic advice, and analysis to law firms, corporations, accounting firms, and governments.
BCPC vs CRAI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $197.0M |
| Net Profit | $40.3M | $13.2M |
| Gross Margin | — | — |
| Operating Margin | 20.5% | 10.5% |
| Net Margin | 14.9% | 6.7% |
| Revenue YoY | 8.1% | 11.6% |
| Net Profit YoY | 8.7% | -12.0% |
| EPS (diluted) | $1.25 | $1.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $197.0M | ||
| Q3 25 | $267.6M | $185.9M | ||
| Q2 25 | $255.5M | $186.9M | ||
| Q1 25 | $250.5M | $181.9M | ||
| Q4 24 | $240.0M | $176.4M | ||
| Q3 24 | $239.9M | $167.7M | ||
| Q2 24 | $234.1M | $171.4M |
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $13.2M | ||
| Q3 25 | $40.3M | $11.5M | ||
| Q2 25 | $38.3M | $12.1M | ||
| Q1 25 | $37.1M | $18.0M | ||
| Q4 24 | $33.6M | $15.0M | ||
| Q3 24 | $33.8M | $11.4M | ||
| Q2 24 | $32.1M | $6.5M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | 10.5% | ||
| Q3 25 | 20.4% | 9.3% | ||
| Q2 25 | 20.1% | 10.6% | ||
| Q1 25 | 20.4% | 14.0% | ||
| Q4 24 | 19.8% | 12.2% | ||
| Q3 24 | 20.0% | 11.0% | ||
| Q2 24 | 19.6% | 6.6% |
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | 6.7% | ||
| Q3 25 | 15.1% | 6.2% | ||
| Q2 25 | 15.0% | 6.5% | ||
| Q1 25 | 14.8% | 9.9% | ||
| Q4 24 | 14.0% | 8.5% | ||
| Q3 24 | 14.1% | 6.8% | ||
| Q2 24 | 13.7% | 3.8% |
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $1.99 | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $1.17 | — | ||
| Q1 25 | $1.13 | — | ||
| Q4 24 | $1.03 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.98 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $18.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $213.6M |
| Total Assets | $1.7B | $628.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $18.2M | ||
| Q3 25 | $65.1M | $22.5M | ||
| Q2 25 | $65.4M | $19.4M | ||
| Q1 25 | $49.9M | $25.6M | ||
| Q4 24 | $49.5M | $26.7M | ||
| Q3 24 | $73.7M | $24.5M | ||
| Q2 24 | $63.7M | $24.6M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $213.6M | ||
| Q3 25 | $1.3B | $201.7M | ||
| Q2 25 | $1.3B | $197.0M | ||
| Q1 25 | $1.2B | $227.3M | ||
| Q4 24 | $1.1B | $212.1M | ||
| Q3 24 | $1.2B | $204.5M | ||
| Q2 24 | $1.1B | $191.7M |
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $628.9M | ||
| Q3 25 | $1.7B | $629.0M | ||
| Q2 25 | $1.7B | $606.8M | ||
| Q1 25 | $1.6B | $590.4M | ||
| Q4 24 | $1.6B | $571.4M | ||
| Q3 24 | $1.6B | $582.3M | ||
| Q2 24 | $1.6B | $546.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | $22.4M |
| Free Cash FlowOCF − Capex | $33.8M | — |
| FCF MarginFCF / Revenue | 12.5% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | 0.99× | 1.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $22.4M | ||
| Q3 25 | $65.6M | $36.5M | ||
| Q2 25 | $47.3M | $5.9M | ||
| Q1 25 | $36.5M | $-80.0M | ||
| Q4 24 | $52.3M | $79.4M | ||
| Q3 24 | $51.3M | $31.6M | ||
| Q2 24 | $45.0M | $1.8M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $35.9M | ||
| Q2 25 | — | $4.7M | ||
| Q1 25 | — | $-81.0M | ||
| Q4 24 | — | $68.8M | ||
| Q3 24 | — | $28.6M | ||
| Q2 24 | — | $-509.0K |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 19.3% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | -44.5% | ||
| Q4 24 | — | 39.0% | ||
| Q3 24 | — | 17.0% | ||
| Q2 24 | — | -0.3% |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 1.4% |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 1.70× | ||
| Q3 25 | 1.63× | 3.19× | ||
| Q2 25 | 1.23× | 0.48× | ||
| Q1 25 | 0.98× | -4.44× | ||
| Q4 24 | 1.56× | 5.30× | ||
| Q3 24 | 1.52× | 2.76× | ||
| Q2 24 | 1.40× | 0.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
